Day: August 13, 2021

Rani Therapeutics Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Rani Therapeutics Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

SAN JOSE, Calif., Aug. 13, 2021 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (Nasdaq:RANI) (“Rani Therapeutics” or “Rani”), a clinical stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics today announced the final closing of its initial public offering of 7,666,667 shares of its Class A common stock, which includes 1,000,000 shares sold pursuant to the full exercise by the underwriters of their option to purchase additional shares, at a public offering price of $11.00 per share. The offering of 6,666,667 shares closed on August 3, 2021. The closing of the underwriters’ partial exercise of 500,000 shares occurred on August 11, 2021, and the closing of the underwriters’ exercise of their remaining option of 500,000 shares occurred on August 13, 2021. The...

Continue reading

TFI International Announces Board Departure of Lucien Bouchard

TFI International Announces Board Departure of Lucien Bouchard

MONTREAL, Aug. 13, 2021 (GLOBE NEWSWIRE) — TFI International Inc. (NYSE and TSX: TFII), a North American leader in the transportation and logistics industry, today announced the retirement of long time independent director Lucien Bouchard from its Board of Directors which he originally joined in 2007. Over his long and distinguished career, Mr. Bouchard served as the Premier of Quebec, Canada’s Secretary of State and Minister of the Environment, was appointed the Canadian Ambassador to France in 1985, and has served on multiple high-profile corporate and non-profit boards. Mr. Bouchard will depart the TFI International Board of Directors effective August 23, 2021. “We will be forever grateful for the insights and perspectives Lucien brought to TFI International over a long period of substantial growth and geographic expansion for...

Continue reading

BigCommerce Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BigCommerce Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

AUSTIN, Texas, Aug. 13, 2021 (GLOBE NEWSWIRE) — BigCommerce Holdings, Inc. (Nasdaq: BIGC), a leading Open SaaS ecommerce platform for fast-growing and established brands, today announced that on August 11, 2021 the Compensation Committee of its Board of Directors granted inducement restricted stock units (“RSUs”) to certain new employees previously affiliated with Feedonomics LLC who were offered employment in connection with the acquisition of Feedonomics’ assets and as inducements material to the new employees entering into employment with BigCommerce. The RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4). An aggregate of 195,339 RSUs were granted to 161 employees. Certain management employees of Feedonomics were granted an aggregate of 90,660 RSUs which vest over four years, with 50% of the shares...

Continue reading

Ceylon Provides Update On Filing Annual Financial Statements

Ceylon Provides Update On Filing Annual Financial Statements

VANCOUVER, British Columbia, Aug. 13, 2021 (GLOBE NEWSWIRE) — Ceylon Graphite Corp. (“Ceylon” or the “Company”) (TSX-V: CYL) (OTC: CYLYF) (FSE: CCY) announces that its application for a management cease trade order (“MCTO”), as previously announced in a news release dated July 30, 2021, has been accepted by the British Columbia Securities Commission (the “BCSC”). The MCTO was issued by the BCSC, effective as of July 30, 2021, in connection with the delay by the Company in filing its annual financial statements, management’s discussion and analysis and related officer certifications for the financial year ended March 31, 2021 (collectively, the “Annual Filings”). The completion of the Annual Filings by the Company and its various Sri Lankan subsidiaries has been delayed as a result of COVID-19...

Continue reading

PFSweb Receives Nasdaq Notice on Late Filing of its Form 10-Q

PFSweb Receives Nasdaq Notice on Late Filing of its Form 10-Q

Notice has No Immediate Effect on the Listing or Trading of the Company’s Shares ALLEN, Texas, Aug. 13, 2021 (GLOBE NEWSWIRE) — PFSweb, Inc. (NASDAQ: PFSW), a global commerce services company, announced that it has received a notice from the Nasdaq Stock Market on August 10, 2021 notifying the company that, because its Form 10-Q for the period ended June 30, 2021 (the “2021 10-Q”) was not filed with the Securities and Exchange Commission by the required due date of August 9, 2021, the company is therefore not in compliance with the periodic filing requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1). This Notice received from Nasdaq has no immediate effect on the listing or trading of the company’s shares. Nasdaq has provided the company with 60 calendar days, until October 11, 2021,...

Continue reading

SAKER AVIATION SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE MONTHS ENDED JUNE 30, 2021

SAKER AVIATION SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE MONTHS ENDED JUNE 30, 2021

Revenue of $1.2 Million in 2021 up 268.8% Versus $439,000 in 2020 Net Income of $577,000 in 2021 Versus Net Loss of $755,000 in 2020 New York, Aug. 13, 2021 (GLOBE NEWSWIRE) — Saker Aviation Services, Inc. (OTCQB: SKAS), an aviation services company specializing in ground-based services to the general aviation marketplace, today announced its financial results for the three months ended June 30, 2021. Revenue in the three months ended June 30, 2021 of $1,179,064, was up 268.8 percent from $438,632 in the three months ended June 30, 2020. Net income in the three months ended June 30, 2021 of $577,164, was up $1,332,099 as compared to net loss of $754,935 in the same period in 2020. “We are pleased to announce a significant and encouraging swing in results for the quarter ended June 30, 2021 as compared to the same period in 2020,”...

Continue reading

Skyline Announces Continued Improvement in Operational Results for Q2 2021

Skyline Announces Continued Improvement in Operational Results for Q2 2021

Q2 2021 Adjusted EBITDA strongly improved to positive $4.5 million versus negative $6.8 million in Q2 2020 and Adjusted EBITDA for the first half of 2021 was 3.9 times higher than the same period in 2020, demonstrating a significant recovery in operations; Q2 2021 funds from operations (“FFO”) improved to $1.4 million, or $0.08 per share compared to Q2 2020 FFO of negative $7.7 million, or negative $0.47 per share; Q2 2021 revenue from Skyline’s hotels and resorts increased by 257% to $24.9 million compared to $7.0 million in Q2 2020, due to improved demand resulting from the trajectory of improvement in the COVID-19 pandemic across North America; The Canadian and US governments continue to provide support to the travel industry, and Skyline received additional benefits during 2021; Unrestricted cash and available lines of credit as at...

Continue reading

KRONOS BRAND BECOMING THE AIR PURIFIER OF CHOICE FOR THE CALIFORNIA SCHOOL DISTRICTS WITH HUNDREDS OF UNITS INSTALLED IN CLASSROOMS

KRONOS BRAND BECOMING THE AIR PURIFIER OF CHOICE FOR THE CALIFORNIA SCHOOL DISTRICTS WITH HUNDREDS OF UNITS INSTALLED IN CLASSROOMS

Parkersburg, WV, Aug. 13, 2021 (GLOBE NEWSWIRE) — KRONOS ADVANCED TECHNOLOGIES, INC. (OTC MARKETS: KNOS) (“KNOS” or the “Company”), innovation-driven product development and production company that has significantly changed the way air is moved, filtered, and sterilized, announced today that the Company increased its inventory and will prioritize shipping for all schools that are now preparing to return to in-person classroom learning. Centers for Disease Control (CDC) had recently published new Guidance for COVID-19 Prevention in K-12 Schools. To review complete CDC recommendations for your school, please visit: https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/k-12-guidance.html Key Takeaways *Students benefit from in-person learning, and safely returning to in-person instruction in...

Continue reading

SEACOR Holdings Inc. Announces Acquisition of U.S. Shipping Corp

SEACOR Holdings Inc. Announces Acquisition of U.S. Shipping Corp

FORT LAUDERDALE, Fla., Aug. 13, 2021 (GLOBE NEWSWIRE) — SEACOR Holdings Inc. (“SEACOR” or “the Company”) announced today the completion of its acquisition of U.S. Shipping Corp (“USSC”), a privately owned, leading provider of long-haul marine transportation for chemical and petroleum cargoes in the U.S. coastwise trade, operating under the Jones Act. The transaction closed on August 13, 2021. “We welcome the USSC team into the growing SEACOR family and look forward to their continued success,” says Eric Fabrikant, Chief Executive Officer of SEACOR. This strategic acquisition positions SEABULK, part of the SEACOR family of companies, as one of the largest Jones Act tanker operators with a fleet of 15 coastwise vessels ranging in size from 150,000 to 330,000 barrels of capacity. “Combining these two fleets and operating teams will...

Continue reading

Brooklyn ImmunoTherapeutics to Present at the SNN Virtual Investor Conference on August 18, 2021

Brooklyn ImmunoTherapeutics to Present at the SNN Virtual Investor Conference on August 18, 2021

NEW YORK, Aug. 13, 2021 (GLOBE NEWSWIRE) — Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders, and monogenic diseases, today announced that Chief Executive Officer Howard J. Federoff, M.D., Ph.D., will present a corporate overview at the SNN Virtual Investor Conference being held August 17 – 19, 2021. Dr. Federoff will deliver his corporate presentation on August 18 at 12:00pm ET. Investors can also request a one-on-one meeting with Dr. Federoff to be arranged throughout the conference. Investors can register here: REGISTER About Brooklyn ImmunoTherapeuticsBrooklyn is focused on exploring the role that cytokine, gene editing, and cell therapy can have...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.